Literature DB >> 27085422

Crystal structure of carbonmonoxy sickle hemoglobin in R-state conformation.

Mohini S Ghatge1, Mostafa H Ahmed1, Abdel Sattar M Omar2, Piyusha P Pagare1, Susan Rosef3, Glen E Kellogg1, Osheiza Abdulmalik4, Martin K Safo5.   

Abstract

The fundamental pathophysiology of sickle cell disease is predicated by the polymerization of deoxygenated (T-state) sickle hemoglobin (Hb S) into fibers that distort red blood cells into the characteristic sickle shape. The crystal structure of deoxygenated Hb S (DeoxyHb S) and other studies suggest that the polymer is initiated by a primary interaction between the mutation βVal6 from one Hb S molecule, and a hydrophobic acceptor pocket formed by the residues βAla70, βPhe85 and βLeu88 of an adjacent located Hb S molecule. On the contrary, oxygenated or liganded Hb S does not polymerize or incorporate in the polymer. In this paper we present the crystal structure of carbonmonoxy-ligated sickle Hb (COHb S) in the quaternary classical R-state at 1.76Å. The overall structure and the pathological donor and acceptor environments of COHb S are similar to those of the isomorphous CO-ligated R-state normal Hb (COHb A), but differ significantly from DeoxyHb S as expected. More importantly, the packing of COHb S molecules does not show the typical pathological interaction between βVal6 and the βAla70, βPhe85 and βLeu88 hydrophobic acceptor pocket observed in DeoxyHb S crystal. The structural analysis of COHb S, COHb A and DeoxyHb S provides atomic level insight into why liganded hemoglobin does not form a polymer.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Allosteric; Crystal structure; Hemoglobin; Mutation; R-state; Sickle cell disease

Mesh:

Substances:

Year:  2016        PMID: 27085422      PMCID: PMC4859812          DOI: 10.1016/j.jsb.2016.04.003

Source DB:  PubMed          Journal:  J Struct Biol        ISSN: 1047-8477            Impact factor:   2.867


  43 in total

1.  Role of hybrid tetramer formation in gelation of haemoglobin S.

Authors:  R M Bookchin; R L Nagel; T Balazs
Journal:  Nature       Date:  1975-08-21       Impact factor: 49.962

Review 2.  Hemoglobin-ligand binding: understanding Hb function and allostery on atomic level.

Authors:  Martin K Safo; Mostafa H Ahmed; Mohini S Ghatge; Telih Boyiri
Journal:  Biochim Biophys Acta       Date:  2011-03-08

Review 3.  Sickle cell anemia and vascular dysfunction: the nitric oxide connection.

Authors:  Idowu Akinsheye; Elizabeth S Klings
Journal:  J Cell Physiol       Date:  2010-09       Impact factor: 6.384

4.  The three-dimensional structure of sickle hemoglobin macrofibers.

Authors:  D A Bluemke; B Carragher; M J Potel; R Josephs
Journal:  Prog Clin Biol Res       Date:  1987

5.  Solubilization of hemoglobin S by other hemoglobins.

Authors:  R E Benesch; R Edalji; R Benesch; S Kwong
Journal:  Proc Natl Acad Sci U S A       Date:  1980-09       Impact factor: 11.205

6.  Some properties of hemoglobin mobile (alpha 2 beta 2 73 Asp----Val).

Authors:  J L Converse; V Sharma; G Reiss-Rosenberg; H M Ranney; E Danish; L S Bowman; J W Harris
Journal:  Hemoglobin       Date:  1985       Impact factor: 0.849

7.  The effects of alpha chain mutations cis and trans to the beta6 mutation on the polymerization of sickle cell haemoglobin.

Authors:  R E Benesch; S Kwong; R Benesch
Journal:  Nature       Date:  1982-09-16       Impact factor: 49.962

8.  Structure of human carbonmonoxyhemoglobin at 2.16 A: a snapshot of the allosteric transition.

Authors:  Martin K Safo; James C Burnett; Faik N Musayev; Samuel Nokuri; Donald J Abraham
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2002-11-23

9.  A third quaternary structure of human hemoglobin A at 1.7-A resolution.

Authors:  M M Silva; P H Rogers; A Arnone
Journal:  J Biol Chem       Date:  1992-08-25       Impact factor: 5.157

10.  Pathophisiology of sickle cell disease and new drugs for the treatment.

Authors:  Lucia De Franceschi
Journal:  Mediterr J Hematol Infect Dis       Date:  2009-12-20       Impact factor: 2.576

View more
  10 in total

1.  Rational modification of vanillin derivatives to stereospecifically destabilize sickle hemoglobin polymer formation.

Authors:  Tanvi M Deshpande; Piyusha P Pagare; Mohini S Ghatge; Qiukan Chen; Faik N Musayev; Jurgen Venitz; Yan Zhang; Osheiza Abdulmalik; Martin K Safo
Journal:  Acta Crystallogr D Struct Biol       Date:  2018-10-02       Impact factor: 7.652

2.  An Investigation of Structure-Activity Relationships of Azolylacryloyl Derivatives Yielded Potent and Long-Acting Hemoglobin Modulators for Reversing Erythrocyte Sickling.

Authors:  Abdelsattar M Omar; Osheiza Abdulmalik; Mohini S Ghatge; Yosra A Muhammad; Steven D Paredes; Moustafa E El-Araby; Martin K Safo
Journal:  Biomolecules       Date:  2020-11-02

Review 3.  Modulating hemoglobin allostery for treatment of sickle cell disease: current progress and intellectual property.

Authors:  Piyusha P Pagare; Aref Rastegar; Osheiza Abdulmalik; Abdelsattar M Omar; Yan Zhang; Andrew Fleischman; Martin K Safo
Journal:  Expert Opin Ther Pat       Date:  2021-11-01       Impact factor: 6.714

4.  Design, Synthesis, and Antisickling Investigation of a Nitric Oxide-Releasing Prodrug of 5HMF for the Treatment of Sickle Cell Disease.

Authors:  Rana T Alhashimi; Mohini S Ghatge; Akua K Donkor; Tanvi M Deshpande; Nancy Anabaraonye; Dina Alramadhani; Richmond Danso-Danquah; Boshi Huang; Yan Zhang; Faik N Musayev; Osheiza Abdulmalik; Martin K Safo
Journal:  Biomolecules       Date:  2022-05-12

5.  Structural and Functional Insight of Sphingosine 1-Phosphate-Mediated Pathogenic Metabolic Reprogramming in Sickle Cell Disease.

Authors:  Kaiqi Sun; Angelo D'Alessandro; Mostafa H Ahmed; Yujin Zhang; Anren Song; Tzu-Ping Ko; Travis Nemkov; Julie A Reisz; Hongyu Wu; Morayo Adebiyi; Zhangzhe Peng; Jing Gong; Hong Liu; Aji Huang; Yuan Edward Wen; Alexander Q Wen; Vladimir Berka; Mikhail V Bogdanov; Osheiza Abdulmalik; Leng Han; Ah-Lim Tsai; Modupe Idowu; Harinder S Juneja; Rodney E Kellems; William Dowhan; Kirk C Hansen; Martin K Safo; Yang Xia
Journal:  Sci Rep       Date:  2017-11-10       Impact factor: 4.379

6.  Substitutions in the β subunits of sickle-cell hemoglobin improve oxidative stability and increase the delay time of sickle-cell fiber formation.

Authors:  Fantao Meng; Tigist Kassa; Michael Brad Strader; Jayashree Soman; John S Olson; Abdu I Alayash
Journal:  J Biol Chem       Date:  2019-01-10       Impact factor: 5.157

Review 7.  Rational Drug Design of Peptide-Based Therapies for Sickle Cell Disease.

Authors:  Olujide O Olubiyi; Maryam O Olagunju; Birgit Strodel
Journal:  Molecules       Date:  2019-12-12       Impact factor: 4.411

8.  Molecular insight into 2-phosphoglycolate activation of the phosphatase activity of bisphosphoglycerate mutase.

Authors:  Anfal S Aljahdali; Faik N Musayev; John W Burgner; Mohini S Ghatge; Vibha Shekar; Yan Zhang; Abdelsattar M Omar; Martin K Safo
Journal:  Acta Crystallogr D Struct Biol       Date:  2022-03-11       Impact factor: 7.652

Review 9.  Metabolic Reprogramming in Sickle Cell Diseases: Pathophysiology and Drug Discovery Opportunities.

Authors:  Dina Alramadhani; Anfal S Aljahdali; Osheiza Abdulmalik; B Daniel Pierce; Martin K Safo
Journal:  Int J Mol Sci       Date:  2022-07-04       Impact factor: 6.208

10.  Plasma Levels of Acyl-Carnitines and Carboxylic Acids Correlate With Cardiovascular and Kidney Function in Subjects With Sickle Cell Trait.

Authors:  Travis Nemkov; Sarah Skinner; Mor Diaw; Saliou Diop; Abdoulaye Samb; Philippe Connes; Angelo D'Alessandro
Journal:  Front Physiol       Date:  2022-07-13       Impact factor: 4.755

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.